Patents-Review.com
ClassID:

95828 āŽ˜

C07F9/062 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds without Pā€”C bonds Organo-phosphoranes without P-C bonds

Sub-classes:
Recent Application in this class:
#1
20260000691
2026-01-01

COMPOUNDS, METHODS, AND TREATMENTS FOR ABNORMAL SIGNALING PATHWAYS FOR PRENATAL AND POSTNATAL DEVELOPMENT

 #2
20250316759
2025-10-09

COMPOUND, ELECTROLYTE INCLUDING THE SAME FOR RECHARGEABLE LITHIUM BATTERY, AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME

 #3
20250276988
2025-09-04

PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS

 #4
20250201922
2025-06-19

ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME

 #5
20250158129
2025-05-15

ELECTROLYTE SOLUTION FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME

 #6
20250034187
2025-01-30

STING AGONISTIC COMPOUND

 #7
20250011353
2025-01-09

PROCESS OF PREPARING HIV CAPSID INHIBITOR

 #8
20240413397
2024-12-12

ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME

 #9
20240336560
2024-10-10

Use of a Multidentate Phosphite Ligand in the Catalytic Synthesis of Adiponitrile

 #10
20240309028
2024-09-19

PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

 #11
20240274884
2024-08-15

ELECTROLYTE AND SECONDARY BATTERY COMPRISING SAME

 #12
20230339992
2023-10-26

STING agonistic compound

 #13
20230253625
2023-08-10

Electrolyte for lithium secondary battery and lithium secondary battery including the same

 #14
20220340605
2022-10-27

Processes for preparing phosphorodiamidate morpholino oligomers

 #15
20220332736
2022-10-20

Diphosphites with an open, 3-methylated outer unit

 #16
20220328876
2022-10-13

Electrolyte Solution for Lithium Secondary Battery and Lithium Secondary Battery Including the Same

 #17
20220263133
2022-08-18

Non-aqueous electrolyte for lithium-ion battery and lithium-ion battery

 #18
20220255120
2022-08-11

NON-AQUEOUS ELECTROLYTE FOR A LITHIUM ION BATTERY AND LITHIUM ION BATTERY COMPRISING THE ELECTROLYTE

 #19
20220110954
2022-04-14

COMPOUNDS, METHODS, AND TREATMENTS FOR ABNORMAL SIGNALING PATHWAYS FOR PRENATAL AND POSTNATAL DEVELOPMENT

 #20
20210371438
2021-12-02

Adducts of triphenylphosphine and triphenylphosphite and their use for the bromination of primary alcohols

 #21
20210363166
2021-11-25

Sting agonistic compound

 #22
20210313622
2021-10-07

Electrolyte for lithium secondary battery and lithium secondary battery including the same

 #23
20210171551
2021-06-10

Process for producing silyl phosphine compound and silyl phosphine compound

 #24
20210087161
2021-03-25

Litter for promoting pet's in-litter elimination

 #25
20210023098
2021-01-28

Salts of prodrugs of piperazine and substituted piperidine antiviral agents

 #26
20210013546
2021-01-14

Electrolyte for rechargeable lithium battery and rechargeable lithium battery including same

 #27
20210005932
2021-01-07

Lithium secondary battery comprising electrolyte

 #28
20200399530
2020-12-24

Aqueous delayed acid system for well stimulation

 #29
20200399295
2020-12-24

Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides

 #30
20200052336
2020-02-13

Lithium secondary battery comprising electrolyte

 #31
20200052333
2020-02-13

Lithium secondary battery

 #32
20200046743
2020-02-13

SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS

 #33
20190367541
2019-12-05

NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS

 #34
20190337878
2019-11-07

Medical lubricant

 #35
20190276480
2019-09-12

Processes for preparing phosphorodiamidate morpholino oligomers

 #36
20190263845
2019-08-29

Process for producing silyl phosphine compound and silyl phosphine compound

 #37
20190237804
2019-08-01

Non-aqueous electrolyte for lithium-ion battery and lithium-ion battery

 #38
20190225605
2019-07-25

DEUTERATED PALBOCICLIB

 #39
20190111066
2019-04-18

SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS

 #40
20180051022
2018-02-22

DEUTERATED PALBOCICLIB

 #41
20180030073
2018-02-01

Natural lipids containing non-oxidizable fatty acids

 #42
20180000849
2018-01-04

SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS

 #43
20170226139
2017-08-10

CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHOROTHIOATE

 #44
20170158719
2017-06-08

Process for reducing the chlorine content of organotetraphosphites

 #45
20170151375
2017-06-01

Biocompatible, biomimetic ampholyte materials

 #46
20170121355
2017-05-04

Process for reducing the chlorine content of organomonophosphites using two solutions

 #47
20160143927
2016-05-26

Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development

 #48
20160074421
2016-03-17

METHOD FOR THE TREATMENT OF DISEASES CAUSED BY HAEMORRHAGIC VIRUSES AND COMPOUNDS FOR USE IN SAID TREATMENT

 #49
20160024125
2016-01-28

NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS

 #50
20160024084
2016-01-28

DEUTERATED PALBOCICLIB

 #51
20150376213
2015-12-31

Phospholipid compound containing unsaturated fatty acid derivative having cyclopropane ring

 #52
20150376120
2015-12-31

Albicidin derivatives, their use and synthesis

 #53
20150158891
2015-06-11

STABLE PHARMACEUTICAL COMPOSITION FOR OPTIMIZED DELIVERY OF AN HIV ATTACHMENT INHIBITOR

 #54
20150141557
2015-05-21

Stabilizer and composition including the same

 #55
20150025240
2015-01-22

SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS

 #56
20150018316
2015-01-15

Compounds, Methods, and Treatments for Abnormal Signaling Pathways for Prenatal and Postnatal Development

 #57
20150011510
2015-01-08

4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator

 #58
20140364624
2014-12-11

Method for manufacturing hydrophilic silicone macromer

 #59
20140342166
2014-11-20

Curable polysiloxane composition

 #60
20140155355
2014-06-05

MAO-B INHIBITORS USEFUL FOR TREATING OBESITY

 #61
20130172574
2013-07-04

Method for manufacturing hydrophilic silicone macromer

 #62
20130053470
2013-02-28

Biocompatible, biomimetic ampholyte materials

 #63
20120238755
2012-09-20

Salts of prodrugs of piperazine and substituted piperidine antiviral agents

 #64
20120015909
2012-01-19

MAO-B INHIBITORS USEFUL FOR TREATING OBESITY

 #65
20110218176
2011-09-08

Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development

 #66
20100210599
2010-08-19

Prodrugs of piperazine and substituted piperidine antiviral agents

 #67
20100056540
2010-03-04

STABLE PHARMACEUTICAL COMPOSITION FOR OPTIMIZED DELIVERY OF AN HIV ATTACHMENT INHIBITOR

 #68
20070004683
2007-01-04

MAO-B inhibitors useful for treating obesity

 #69
20050209246
2005-09-22

Prodrugs of piperazine and substituted piperidine antiviral agents